The Technical Analyst
Select Language :
Evelo Biosciences Inc [EVLO]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology

Evelo Biosciences Inc Price, Forecast, Insider, Ratings, Fundamentals & Signals

Evelo Biosciences Inc is listed at the  Exchange

3.45% $0.0450

America/New_York / 28 mar 2024 @ 15:35


Evelo Biosciences Inc: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 0.854 mill
EPS: -15.64
P/E: 0
Earnings Date: May 12, 2024
SharesOutstanding: 18.98 mill
Avg Daily Volume: 0.0482 mill
RATING 2024-03-28
B-
Neutral
RATINGS
Rating CashFlow: Strong Buy
Return On Equity: Strong Buy
Return On Asset: Strong Sell
DE: Strong Sell
P/E: Sell
Price To Book: Strong Sell
QUARTER GROWTHS
2/223/224/221/232/233/23
Revenuen/an/an/an/an/an/a
Gr.Profitn/an/an/an/an/a
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE 0 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
N/A
Company: PE 0 | industry: PE 5.88
DISCOUNTED CASH FLOW VALUE
N/A
N/A
Expected Trading Range (DAY)

$ 0.0270 - 0.0630

( +/- 40.00%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2023-11-07 Bodmer Mark Buy 6 625 Common Stock
2023-11-08 Bodmer Mark Sell 3 163 Common Stock
2023-11-07 Bodmer Mark Sell 6 625 Restricted Stock Units
2023-11-07 Mchale Duncan Buy 6 500 Common Stock
2023-11-08 Mchale Duncan Sell 3 103 Common Stock
INSIDER POWER
86.75
Last 96 transactions
Buy: 11 679 076 | Sell: 749 652

Forecast: 16:00 - $0.0450

Live Trading Signals (every 1 min)

Forecast 1: 15:45 - $0.0470
Forecast 2: 16:00 - $0.0450
Forecast 3: 16:00 - $0.0450
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
Volume Signals
Price $0.0450 (3.45% )
Volume 0.0324 mill
Avg. Vol. 0.0482 mill
% of Avg. Vol 67.20 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Evelo Biosciences Inc

Last 12 Months

Last 12 months chart data with high, low, open and close for Evelo Biosciences Inc

RSI

Last 10 Buy & Sell Signals For EVLO

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Profile picture for
            Evelo Biosciences Inc

EVLO

Evelo Biosciences, Inc., a biotechnology company, discovers and develops oral biologics for the treatment of inflammatory diseases and cancer. It is developing EDP1815, a whole-microbe candidate for the treatment of inflammatory diseases; and is in Phase 2 clinical trial for the treatment of psoriasis and atopic dermatitis, as well as for the hyperinflammatory response associated with COVID-19. The company also develops EDP1867, an inactivated investigational oral biologic, which is in Phase 1b for the treatment of inflammatory diseases; EDP2939, an extracellular vesicle investigational oral biologic for the treatment of inflammatory diseases; and EDP1908, a product candidate for oncology. Evelo Biosciences, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts.

Last 10 Buy Signals

Date Signal @
TRBUSDMar 28 - 17:4694.12
TKXUSDMar 28 - 17:4414.97
KWENTAUSDMar 28 - 17:44113.76
AVAXUSDMar 28 - 17:45$54.54
SANTOSUSDMar 28 - 17:407.79
KUJIUSDMar 28 - 17:382.73
BICOUSDMar 28 - 17:380.622
ARBUSDMar 28 - 17:391.680
BONDUSDMar 28 - 17:395.11
1INCHUSDMar 28 - 17:390.600

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.